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Cranial irradiation therapy (CRT), in combination with a variety of
chemotherapeutic regimens, has now been used in the treatment 
of childhood acute lymphoblastic leukaemia (ALL) for over 25
years. Prior to the introduction of CRT, these children had a life
expectancy of less than 1 year, but today approximately 70% of
childhood victims survive the disease. While CRT is no longer
universally employed in treatment protocols for ALL, there
remain large numbers of childhood survivors who are now in
continuous remission and quality of life issues are of increasing
concern. Research suggests that many children treated with CRT
and chemotherapy experience cognitive, educational and behav-
ioural difficulties, with the degree of deficit associated with a
range of treatment-based and psychosocial factors (Brouwers et al,
1990; Anderson et al, 1994; Jankovic et al, 1994). The majority of
studies link such neurobehavioural deficits specifically to the
administration of CRT, or a possible synergistic effect of CRT and
chemotherapy in combination (Goff et al, 1980; Ivnik et al, 1981;
Gamis et al, 1991; Hallberg et al, 1991; Waber et al, 1995). There
is little documentation of the possible sequelae of chemotherapy
alone, although some recent research has suggested that similar
impairments may occur (Brown et al, 1992; Kaufmann et al,
1996). As many treatment protocols now omit CRT in preference
to chemotherapy, clarification of the relative impact of the various
treatments is of clinical relevance.
While it is now well established that neurobehavioral impair-
ments do occur in association with CRT and chemotherapy admin-
istered in childhood, there is uncertainty with respect to
progression of these problems. It remains unclear whether these
deficits stabilize or diminish with time since treatment, or if there
may be an ongoing decline in abilities. While histological and
radiographic studies have revealed evidence of delayed
neuropathology following CRT and chemotherapy (McIntosh et
al, 1977; Constine, 1991; Fernandez-Bouzas et al, 1992; Paakko et
al, 1992; Valk et al, 1992; Bakke et al, 1993; Matsumoto et al,
1995; Moore, 1995), there has been little systematic examination
of related changes in neurobehavioural skills over time. A handful
of early studies found no evidence of intellectual and educational
decline following therapy (Tamaroff et al, 1982; Moehle et al,
1985; Mulhern et al, 1991). Other longitudinal research indicates
that declines in these abilities do occur (Meadows et al, 1981;
Stehbens et al, 1983), but may be unique to specific risk factors,
such as younger age at treatment (Jannoun and Chessels, 1987) or
higher doses of CRT (Silber et al, 1992), or that they may take
some time to ‘emerge’ following treatment (Rubenstein et al,
1990).
While these results do support a decline in abilities with time,
interpretation of such findings is problematic. Test–retest practice
effects on test measures, which often involve increases of up to ten
IQ points per administration, must be considered, and may mask
presence of true deterioration of abilities. Such factors are particu-
larly relevant for studies where children are administered the same
test on several occasions (e.g. Jannoun and Chessels, 1987;
Mulhearn et al, 1991). Additionally, the possible impact of
‘psychosocial’ variables, such as gender, quality of the child’s
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tional interventions may result in changes unrelated to treatment
factors (Taylor and Alden, 1997). Few studies have considered
such factors when interpreting changes in ability in this popula-
tion.
This study aimed to extend previous research, to document the
development of children treated with CRT and chemotherapy
more than 5 years post-treatment, while minimizing the
confounding effects of varying treatment factors. For irradiated
children, only those treated with 18 Gy were included, as (i) the
neurobehavioural deficits of higher doses of CRT are now well
established; and (ii) this lower dose group is more representative
of current treatment practices. Further, only children treated at or
before age 5 were examined, as this is considered to be at ‘high
risk’ age group with respect to neurobehavioural impairment. It is
considered that the developing central nervous system (CNS) may
be particularly vulnerable to toxic agents during this time.
Based on reports which describe residual CNS abnormalities,
and sometimes ongoing degeneration following CRT in children,
it was predicted that children treated with CRT and chemotherapy
would exhibit increasing intellectual and educational difficulties
over time when compared to healthy control children. In keeping
with the results from previous research, we hypothesized that the
greatest impairments would continue to be in non-verbal and
information processing skills (attention, speed of processing).
While less is known about outcome following treatment with stan-
dard chemotherapy protocols, the lack of impairment exhibited by
this group in our initial research (Anderson et al, 1994) led us to
predict that children administered chemotherapy alone would not
experience decline in neurobehavioural abilities, but rather, they
would demonstrate developmental trajectories similar to those of
healthy control children.
PATIENTS AND METHODS
Participants
The children described in this study represent a subset of the total
group evaluated in our previous studies (Anderson et al, 1994;
Smibert et al, 1996). The present sample comprised three groups of
children: Group 1 (n = 35): survivors of ALL, treated with cranial
irradiation (18 Gy) and chemotherapy; Group 2 chemotherapy only
group (n = 19): survivors of other forms of cancer (no CNS
involvement) treated with chemotherapy only; and Group 3 (n =
35): healthy control children. For CRT and chemotherapy only
groups, only children in remission since initial treatment, who had
completed a single course of therapy were included. Initial assess-
ment occurred no less than 2 years after the cessation of treatment,
to ensure children were physically recovered, had returned to
school and were leading a relatively normal life. For all groups,
children with a premorbid history of developmental, neurological
or psychiatric disorder were excluded from the sample.
Children considered for inclusion in the CRT group had been
treated for ALL at the Royal Children’s Hospital, Melbourne,
between 1977 and 1987 according to the ANZCCSG Study (V)
protocol (Waters, 1992). Cranial irradiation was administered
between 2 and 5 years of age, after children had achieved remis-
sion following induction chemotherapy. Each child received a
course of cranial irradiation (18 Gy) in combination with four
doses of intrathecal methotrexate given at weekly intervals.
Children also received two doses of intrathecal methotrexate, prior
to irradiation, given on day 1 and day 21 of the chemotherapy
regimen.
From the original sample (n = 100), 39 children met the criteria
for follow-up: (i) dose of CRT administered = 18 Gy; (ii) age at
treatment less than 5 years; and (ii) aged 7–13 years at first assess-
ment. Four eligible children were unable to be contacted.
The chemotherapy only group comprised children with an
initial diagnosis of ALL, acute myeloid leukaemia (AML) or 
solid tumour, with no CNS involvement, treated only with
chemotherapy. The composition of the group, in terms of aeti-
ology, is relatively heterogeneous, reflecting the lower survival
rate for these conditions in comparison to ALL, and the difficulty
in enrolling large numbers of children in longitudinal research.
From the original sample of children treated with chemotherapy
only (n = 50), 31 children met the criteria for follow-up and 19
agreed to participate. Twelve eligible children had either died in
the intervening 3-year period or were unable to be contacted.
All 19 children in Group 2 received systemic (intravenous)
chemotherapy, with methotrexate at standard dose (Waters, 1992).
The group comprised 2 children with a diagnosis of ALL and 2
children had non-Hodgkin’s lymphoma. These children received
chemotherapy treatment according to the same protocol as chil-
dren in the CRT group (Waters, 1992). Five children had acute
myeloid leukaemia (AML) and were treated according to the then
current AML protocol (Tiedemann et al, 1993). Five had Wilms’
tumours, and were treated using the appropriate protocol (Hutson
et al, 1983). The remaining four children had diagnoses of rhabdo-
myosarcoma, Ewing’s tumour and hepatoblastoma, and each
received treatment according to the then current protocol. Within
this group ten children received intrathecal methotrexate (ALL,
AML, non-Hodgkin’s lymphoma), and nine had intravenous
chemotherapy alone.
The healthy comparison group was initially recruited from
schools within the Melbourne metropolitan area, and the original
sample (n = 100) is described in Anderson et al (1994). The
healthy comparison group (n = 35) employed in the follow-up
study was selected from the original sample, to match the CRT
group as closely as possible for age, gender and SES. Only chil-
dren aged under 17 years at T2 were invited to participate in the
follow-up study, due to age requirements for testing.
Demographic and treatment characteristics for the groups
included in the follow-up study are provided in Table 1. All chil-
dren invited to participate in the follow-up study agreed to do so.
Statistical comparisons of demographic, intellectual and educa-
tional variables for the initial and follow-up samples confirmed
that the samples selected for follow-up did not differ significantly
from the original samples on these variables. For the
chemotherapy only samples, the follow-up group achieved
marginally lower intellectual and educational scores at initial
assessment. These group differences only reached statistical
significance for Spelling. This trend suggests that the
chemotherapy only group described in this study may represent a
marginally lower functioning sample, than that described in our
original study. The impact of this potential sample bias would be
to increase the chances of the chemotherapy only group
performing more poorly, and thus similarly to CRT group. In our
original study, the chemotherapy only group was indistinguishable
from healthy controls on intellectual and educational measures
(see Anderson et al, 1994).
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Families were contacted by letter to participate in the study, and
required to provide written, informed consent prior to their inclu-
sion in the study, in keeping with hospital ethics requirements.
Three years after the original assessment, families with children
meeting the revised selection criteria were contacted with an invi-
tation to undergo reassessment. Children were assessed in a single
2-h session by a child psychologist.
The Wechsler Intelligence Scale for Children – Revised (WISC-
R: Wechsler, 1974) was employed as a measure of intellectual
performance. Individual subtest scaled scores were calculated as
well as Full Scale (FSIQ), Verbal (VIQ) and Performance (PIQ)
intellectual quotients. The Wide Range Achievement Test – Revised
(WRAT-R: Jastak et al, 1984), which includes Reading, Spelling
and Arithmetic subtests, provided a measure of educational abili-
ties. Both tests were administered at initial (T1) and follow-up
(T2) evaluations.
At T1 and T2 parents and children also completed question-
naires which provided information regarding medical, family and
educational factors, and any changes occurring between evalua-
tions. Parental occupations were recorded, with the occupation of
the principal breadwinner used to determine socioeconomic status
(SES). The Daniel Scale of Occupational Prestige (Daniels, 1983)
was used to quantify these data, using a 7-point rating where
higher scores denote lower SES.
At the completion of the initial assessment, all participants were
provided with copies of an information booklet derived from earlier
research with this population (Godber et al, 1993), which outlined
strategies to aid school-based learning. Additional intervention 
was provided according to the level of impairment exhibited 
by the child. This intervention was categorized as follows, 
with higher codes reflecting a greater degree of intervention: (1) no
feedback; (2) verbal feedback of assessment results to parents; (3)
verbal feedback plus recommendations and written report to family
only; (4) verbal feedback plus recommendations and written report
to family and telephone advice to school; (5) verbal feedback plus
recommendations and written report to family and telephone advice
to school together with documentation of educational intervention
by school. The nature of feedback was consistent, outlining the
child’s cognitive and educational strengths and weaknesses, and
suggesting strategies for intervention based on a compensatory
approach (Hartlage et al, 1983), that is using the child’s strengths to
overcome weaknesses, with detailed information and strategies
available in the booklet provided (Godber et al, 1993).
Statistical analysis
Group differences for demographic and treatment variables were
examined using analysis of variance (ANOVA). For intellectual
and educational data, repeated measures ANOVAs (Group ´ Time
´ Sex) were conducted across the three groups for T1 and T2
results. Where statistical differences were identified post-hoc
analyses were employed to determine group differences. Further,
non-parametric analyses (c2) were performed on cognitive and
educational data to investigate the frequency of significant
changes in performances from T1 to T2. A significant increase in
performance on these measures was defined as a T2 score more
than 5 points higher than that achieved at T1. Similarly, a signifi-
cant decrease was recorded where T2 score was more than 5 points
less than that achieved at T1. Where T1 and T2 scores varied by
less than 5 points, results were considered stable or unchanged.
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Table 1 Sample characteristics
Group 1 Group 2 Group 3
(CRT + chemotherapy) (Chemotherapy only) (Healthy controls)
n 35 19 35
Number of males 17 11 18
Age at testing (years) M (s.d.) 12.9 (1.9) 14.2 (2.0) 13.2 (1.8)
Socio-economic status* M (s.d.) 4.9 (1.0) 4.1 (2.3) 4.1 (1.1)
Time since testing (years) M (s.d.) 3.1 (1.6) 4.7 (0.6) 3.1 (0.3)
Age at diagnosis (years) M (s.d.) 3.0 (1.0) 4.4 (2.3) –
Time since treatment (years) M (s.d.) 9.7 (2.6) 9.8 (1.7) –
* Daniel’s Scale of Occupational Prestige.
Table 2 Educational interventions implemented between T1 and T2 for the three groups*
Group 1 Group 2 Group 3
(CRT + chemotherapy) (Chemotherapy only) (Healthy controls)
n 35 19 35
No verbal feedback n (%) – – 22 (62.9)
Verbal feedback only n (%) 13 (37.1) 13 (68.4) 9 (25.7)
Verbal + written report n (%) 8 (22.9) 1 (5.3) –
Verbal + written report + school liaison n (%) 6 (17.1) 1 (5.3) 3 (8.6)
Verbal + written report + school liaison +
documented intervention by school n (%) 8 (22.9) 4 (21.0) 1 (2.8)
* All participants received a booklet outlining appropriate educational strategies.A series of hierarchical multiple regressions was conducted to
investigate predictors of intellectual and educational outcome.
Predictors were entered into analyses as follows: intellectual
ability (FSIQ) was entered in the first block, with group member-
ship, T1–T2 interval, SES, gender and level of educational inter-
vention entered in subsequent steps.
RESULTS
Table 1 provides treatment and demographic characteristics of the
three groups. No significant group differences were found for age
at testing, time interval between assessments, gender or SES. The
group breakdown for educational interventions received from T1
to T2 is provided in Table 2. Examination of these data indicated
that, as expected, children experiencing more severe intellectual
and educational difficulties were more likely to receive higher
levels of intervention, and associated with this trend, the CRT
group also received more intervention.
Between group comparisons
Means and standard deviations (s.d.) for intellectual and educa-
tional variables are provided in Table 3. Repeated measures
analysis of variance was performed to investigate group and time
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Table 3 Results for intellectual and educational measures at T1 and T2.
Group 1 (n = 35) Group 2 (n = 19) Group 3 (n = 35)
(CRT + chemotherapy) (Chemotherapy only) (Healthy controls)
T1 T2 T1 T2 T1 T2
M (s.d.) M (s.d.) M (s.d.) M (s.d.) M (s.d.) M (s.d.)
WISC-R:
FIQ M (SD)a 93.2 (13.1) 91.0 (12.6) 101.8 (13.6) 100.7 (13.8) 107.3 (12.4) 107.2 (10.4)
VIQ M (SD)a,b 91.9 (15.1) 89.9 (14.0) 101.1 (14.9) 98.5 (13.2) 105.6 (12.0) 101.7 (10.9)
PIQ M (SD)a,c 96.3 (12.4) 94.1 (11.4) 101.8 (12.7) 103.4 (15.3) 108.0 (12.8) 112.5 (10.3)
WRAT-R
Reading M (SD)a,c 86.1 (17.4) 91.5 (16.9) 96.1 (19.1) 93.6 (15.8) 102.1 (15.2) 101.9 (11.6)
Spelling M (SD)a 85.7 (16.7) 90.9 (15.4) 95.2 (18.2) 95.4 (16.3) 101.8 (14.0) 101.5 (14.3)
Arithmetic M (SD)a 86.7 (12.5) 86.9 (15.4) 100.3 (16.4) 93.9 (15.0) 99.5 (11.1) 97.7 (14.6)
a Significant group difference. bSignificant time difference. c Significant group ´ time interaction.
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Figure 1 Comparison of intellectual profiles (WISC-R) for the three groups at T1 and T2. Abbreviations: Information (INF), Similarities (SIM), Arithmetic
(ARIT), Vocabulary, (VOC), Comprehension (COMP), Digit Span (DS), Picture Completion (PC), Picture Arrangement (PA), Block Design (BD), Object
Assembly (OA), Coding (COD)effects for summary IQ and educational measures. For intellectual
measures, significant Group differences were identified for all
summary measures (FSIQ: F(2,86) = 14.04, P < 0.001: VIQ:
F(2,86) = 9.32, P < 0.001; PIQ: F(2,86) = 15.0, P < 0.001), with
post-hoc analyses indicating that the CRT group performed signi-
ficantly more poorly than comparison groups. A significant Time
effect was detected for VIQ (F(1,86) = 8.88, P < 0.01), with scores
for all groups decreasing from T1 to T2. This finding is unex-
pected and may be related to the psychometric and cultural para-
meters of the test, rather than to a true decline in verbal skills. No
significant gender effects were identified. A Group ´ Time interac-
tion (F(2,87) = 5.42, P < 0.01) was detected for PIQ, with chemo-
therapy only and controls showing increases in scores over time,
possibly due to test practice effects. The CRT group, in contrast,
recorded a mean decrease of 2.3 IQ points in PIQ from T1 to T2.
Intellectual profiles for three groups are illustrated in Figure 1,
showing mean scaled scores for each subtest at T1 and T2.
Repeated measures MANOVAs were conducted for Verbal and
Performance scale subtests separately. For Verbal subtests, which
tap linguistic abilities and verbal knowledge, significant main
effects were detected for both Group and Time (Group: Pillais
criterion = 0.43, P < 0.001; Time: Pillais criterion = 0.17. P =
0.01). Univariate F tests detected significant Group differences on
all verbal subtests (P < 0.001), with the exception of Vocabulary.
Significant Time effects were evident for Similarities (F(1,86) =
4.04, P < 0.05) and Vocabulary (F(1,86) = 5.69, P < 0.05), with all
groups improving their scores from T1 to T2, and for Digit Span
(F(1,86) = 6.51, P < 0.01) where comparison groups exhibited an
increase in scaled scores, but the CRT group recorded a decrease in
performance. Only Digit Span, a measure of information
processing capacity, showed a significant interaction effect
(F(2,86) = 5.73, P < 0.01), with the CRT group showing a decrease
in scaled scores from T1 to T2, while the other two groups
improved their performances.
For Performance subtests, tapping visual skills, processing
speed, planning and problem solving, significant effects were
found for Group (Pillais criterion = 0.32, P = 0.01), with no main
effect of Time and no interaction effect. Univariate F test results
showed Group differences (P < 0.01) for all Performance scale
subtests except Picture Arrangement, with the CRT group consis-
tently achieving lowest scores. All groups improved over time for
the Coding subtest (F(1,86) = 6.15, P < 0.01), and interactions
were found for Block Design (F(2,86) = 3.28, P < 0.05) and Object
Assembly (F(2,86) = 3.52, P < 0.05), with the CRT group showing
a decrease in scores from T1 to T2, compared to a small increase
for comparison groups.
On the WRAT-R, repeated measures ANOVA identified a
significant Group effect for all subtests (Reading: F(2,86) = 6.67,
P < 0.01; Spelling: F(2,86) = 7.78, P < 0.001; Arithmetic: F(2,86)
= 8.85, P < 0.001), with the CRT group performing consistently
more poorly at both T1 and T2. No significant Time effect was
identified for any of the educational measures. A gender effect was
found for Spelling only (F(1,86) = 9.40, P < 0.001), with girls
exhibiting better spelling skills overall. A Group ´ Time interac-
tion was detected for Reading (F(2,85) = 4.13, P < 0.05), with the
CRT group showing some gains from T1 to T2 on this measure,
compared to small decreases in scores for comparison groups. This
pattern of performance was also noted for Spelling, although the
effect was not statistically significant.
Finally, for each child, ‘change scores’ were calculated for VIQ,
PIQ, FSIQ and WRAT-R subtests by comparing T1 and T2 scores,
and are illustrated in Table 4. All children were categorized as
demonstrating decreased, increased or stable scores over time, as
defined above. Chi square results, comparing change scores across
groups, showed no significant group differences for FSIQ or VIQ.
However, for PIQ, group differences were significant (c2
4 = 10.18,
P < 0.05), with children treated with CRT most likely to record
significant declines in performance over time, and, conversely,
least likely to demonstrate improved scores. For educational
measures, no significant group differences were evident for arith-
metic skills or spelling. However, for reading, children with CRT
were more highly represented in the ‘improved results’ category
(c2
4 = 10.59, P < 0.05), with 60% of these children exhibiting a
significant increase in reading scores.
Within group analyses
A series of hierarchical multiple regressions was conducted to
investigate predictors of intellectual and educational outcome at
T2. Predictors were entered into the analysis as follows: FSIQ: T1,
to account for factors effecting children’s performance prior to
initial testing, Group, T1–T2 interval, SES, gender, and level of
educational intervention. The results of these analyses are summa-
rized in Table 5. For intellectual variables, the regression equations
employed were able to explain approximately two-thirds of the
variance, with overall intellectual abilities at T1 highly predictive
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Table 4 Percentage of children demonstrating significant changesa in performance from T1 at T2
Group 1 (n = 35) Group 2 (n = 19) Group 3 (n = 35)
(CRT + chemotherapy) (Chemotherapy only) (Healthy controls)
Decrease Increase Decrease Increase Decrease Increase
n (%) n (%) n (%) n (%) n (%) n (%)
WISC-R:
FIQ 13 (37.1) 6 (17.1) 7 (36.8) 4 (21.1) 8 (22.9) 8 (22.9)
VIQ 13 (37.1) 7 (20.0) 9 (47.4) 7 (36.8) 19 (54.3) 6 (7.1)
PIQ* 14 (40.0) 6 (17.1) 5 (26.4) 7 (36.8) 4 (11.4) 16 (45.6)
WRAT-R
Reading* 7 (20.0) 21 (60.0) 7 (36.8) 2 (10.5) 12 (34.3) 14 (40.0)
Spelling 6 (17.1) 20 (57.1) 5 (26.3) 8 (42.2) 10 (28.6) 9 (25.7)
Arithmetic 2 (5.7) 12 (34.3) 10 (52.6) 2 (10.5) 19 (54.3) 9 (25.7)
*P < 0.05. aSignificant change is defined as follows: decrease, T2 score is more than 5 points below T1 score; increase, T2
score is more than 5 points above T1 score.of results at T2. For FSIQ and PIQ, group membership (CRT
group) and longer time since treatment were predictive of poorer
outcome, reflecting slower speed of processing and non-verbal
skills. For VIQ higher SES was related to higher T2 scores. Level
of educational intervention and gender were unrelated to intellec-
tual performance 5 years post-treatment.
Regression analyses for the WRAT-R subtests accounted for
less of the overall variance (36–46%), suggesting that future
research may need to consider a broader range of predictor vari-
ables. Once again, intellectual ability was a strong predictor of
educational ability at T2. For Reading and Spelling ability, level of
educational intervention was a significant predictor of perfor-
mance at T2, with greater educational intervention related to
improvements in performance. Gender also predicted Spelling
ability, with females scoring more highly on these tasks. Group
membership, SES, and time since treatment were not predictive of
outcome for any of the educational measures. For arithmetic
ability none of the predictor variables included in the regression
model had an impact on outcome.
DISCUSSION
The present study aimed to investigate change in intellectual and
educational skills over time for survivors of childhood cancers
treated prior to age 5 years. Three groups were compared: those
treated with CRT and chemotherapy, those treated with
chemotherapy alone, and healthy controls. Groups were similar
with respect to age at testing, gender and socioeconomic status. At
initial evaluation, not less than 2 years post-treatment, significant
differences were identified across groups. The ‘CRT group’
performed most poorly on all measures, and those treated with
‘chemotherapy only’ achieved results similar to healthy controls,
consistent with previous research. The results of the CRT group on
intellectual measures fell two-thirds of a standard deviation below
the test mean on average. While this does not represent a severe
intellectual impairment, such a deficit is of clinical significance,
and would be expected to reduce the capacity of these children to
function adequately within their environment.
To establish the predicted deterioration over time following
CRT and chemotherapy treatments, it was necessary to identify a
Group ´ Time interaction for outcome measures. Thus, not only
should treated children perform poorly at initial evaluation, but
their development trajectories from T1 to T2 should be flatter than
those observed for healthy controls. Such a pattern of results
would support the presence of an increasing gap between the
normal development exhibited by comparison groups, and that of
the CRT group. At follow-up evaluation this pattern of interactions
was present for some variables, but it was not consistently identi-
fied, failing to support an interpretation of generally slowed devel-
opment or deterioration in skills. Similarly, there was no evidence
of ‘recovery’ or catchup of abilities over time for the CRT group.
All groups recorded a small decline in VIQ scores, which tap
linguistic competence and verbal intelligence. Analysis of subtest
performances, as illustrated in Figure 1, indicates that this decline
was particularly marked for tests tapping expressive language
skills (Similarities, Vocabulary), where all groups recorded poorer
scores at T2. With the exception of the Digit Span subtest, this
pattern of lower scores was reflected in all verbal subtests, and
may represent psychometric limitations of the test employed, or
perhaps cultural factors. These results do not indicate a differential
fall off in verbal abilities associated with the administration of
CRT. In contrast, for the Digit Span subtest, a measure of auditory
processing capacity, a Group ´ Time interaction effect was identi-
fied. Analysis of results showed that chemotherapy only and
control groups showed improved age-scaled scores from T1 to T2.
In contrast, the CRT group exhibited a significant decline in these
scores. These data suggest that, in addition to suffering an initial
impairment in information processing skills, children treated with
CRT and chemotherapy may exhibit a slowed rate of development
of these skills.
Similar trends were identified for PIQ, with the CRT group
recording slightly lower scores overall at follow-up, and the
chemotherapy only and healthy controls exhibiting a corresponding
increase in their scores. The increased Performance IQ scores of the
latter groups may be expected due to the known practice effects on
the IQ measure (Wechsler, 1974). Further examination of trends for
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Table 5 Predictors of intellectual and educational outcome at T2 following cranial irradiation and chemotherapy
Predictor variables FSIQ VIQ PIQ WRAT-R WRAT-S WRAT-A
FSIQ (T1) Beta 0.78 0.71 0.74 0.44 0.53 0.70
t value 12.18 9.45 8.64 3.53 3.76 6.07
P 0.001 0.001 0.001 0.001 0.001 0.001
Group Beta 2.85 11.15 4.51 –1.02 –0.18 1.70
t value 2.30 0.81 2.80 –0.44 –0.08 0.78
P 0.02 NS 0.006 NS NS NS
Time since treatment Beta –1.74 –0.88 –2.60 –0.65 –0.20 –1.11
t value –2.06 –0.89 –2.32 0.40 –0.12 –0.73
P 0.04 NS 0.02 NS NS NS
SES Beta –0.50 –1.66 1.22 –1.10 –1.15 1.05
t value –0.70 –2.00 1.29 –0.80 –0.85 0.82
P NS 0.05 NS NS NS NS
Gender Beta –0.18 –0.63 –0.06 4.20 6.93 2.50
t value –0.13 –0.37 –0.03 1.50 2.50 1.00
P NS NS NS NS 0.01 NS
Intervention Beta –0.50 –0.16 –0.87 –2.44 –3.26 –0.80
t value –0.80 –0.22 –1.05 –2.03 –2.74 –0.71
P NS NS NS 0.05 0.008 NS
R2 0.79 0.70 0.65 0.36 0.39 0.46individual subjects for PIQ suggested that there were significantly
more children in the CRT group who showed a decline in test
scores (T2 5 points less than T1 (CRT: 40.0%; chemotherapy only:
26.4%; controls: 11.4%)), and conversely, less exhibited a score
increase (T2 5 points more than T1 (CRT: 17.1%; chemotherapy
only: 36.8%; controls: 45.6%). This decrease in scores exhibited by
the CRT group may not necessarily reflect a true deterioration, but
rather is likely to represent slower than expected development in
non-verbal abilities and information processing skills tapped by the
Performance Scale. Interestingly, this pattern of greater ‘decline’ in
scores at an individual level was not so marked for other measures.
These findings are not consistent with a generalized decline in
abilities or a global lag in development associated with CRT and
chemotherapy. Rather, specific areas of ability were observed to be
more susceptible to time effects. Non-verbal skills and information
processing, which have been previously identified as areas of
greatest difficulty following treatment in young children
(Copeland et al, 1985, 1988; Rourke, 1987; Cousens et al, 1988;
Rogers et al, 1992; Smibert et al, 1996; Anderson et al, 1997),
show poorest development over time, suggesting a cumulative
pattern of cognitive impairment. In contrast, verbal abilities main-
tained development for both treatment groups.
Contrary to expectations of ongoing deterioration, the CRT
group exhibited greater than expected improvements in reading
and spelling, in contrast to comparison groups which recorded age
appropriate increments. These improvements may be associated
with both the level of ability of the child and the educational 
interventions implemented following T1 assessment. The test
employed in this study (WRAT-R Reading) measures single word
reading only, and may not necessarily generalize to other aspects
of reading such as comprehension and fluency, and thus uncer-
tainty remains with respect to the full functional implications of
these results. However, to our knowledge no other longitudinal
study examining residual deficits following CRT and chemo-
therapy has attempted to document these factors, or even report
whether such interventions have occurred. Our results do indicate
a positive response to the provision of feedback regarding the
child’s intellectual and educational strengths and weaknesses and
details regarding appropriate intervention strategies. Greater
improvement occurred where written information was available to
both parents and schools. The nature of the deficits detected in the
initial study suggest that these children treated with CRT and
chemotherapy are able to learn, but may do so more slowly than
other children. The implication from these findings is that appro-
priate intervention may minimize educational deficits and reduce
the development of secondary psychosocial problems. An alterna-
tive explanation is that these educational gains may reflect a
‘delay’ or developmental lag associated with treatment, where
children show initial difficulties, but ‘catch up’ to their peers over
time. Such a position is not supported by intellectual outcomes
indicating stable development at best.
These findings are consistent with developmental models
purporting the susceptibility of the immature brain. While
neuroanatomical studies provide evidence for ongoing CNS
changes following early brain damage, our results argue for a
similar association for cognitive development. The observation of
cumulative deficits in specific cognitive domains (that is, informa-
tion processing, non-verbal abilities) suggests that skills which are
in a critical phase of development during treatment may be partic-
ularly susceptible to disruption (Dennis, 1989). Results also
support previous research identifying greatest impairments when
CRT is included in treatment protocols. In this study children
treated with standard chemotherapy protocols were indistinguish-
able from healthy control children at both T1 and T2, suggesting
no detectable detrimental effects associated with their treatment.
When CRT is added to the treatment protocol, intellectual and
educational deficits occur, with results suggesting an impairment
of clinical significance (two-thirds of a standard deviation below
expected mean). The conclusion may be drawn that either CRT
alone, or a synergistic effect of CRT and chemotherapy, is associ-
ated with neurobehavioural sequelae in young children.
In conclusion, our findings indicate that children treated with
CRT (18 Gy) and chemotherapy prior to age 5 years are at risk for
ongoing intellectual and educational difficulties post-treatment.
While some of these deficits remain constant over time (language
skills, verbal knowledge), others increase (information processing,
non-verbal abilities), reflecting a failure to develop as expected
even many years post-treatment. This pattern was not exhibited for
children treated with chemotherapy alone, who were largely indis-
tinguishable from healthy controls. Further, provision of informa-
tion regarding children’s cognitive and educational strengths and
weaknesses was noted to be associated with improvement in
literacy skills, suggesting that appropriate intervention may
ameliorate the negative effects of treatment. Future studies are
needed to further investigate the efficacy of intervention following
CRT and chemotherapy in children.
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